A pilot study of tremelimumab, a monoclonal antibody against CTLA-4, in combination with either transcatheter arterial chemoembolization (TACE) or radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC).
Austin G. Duffy
No relevant relationships to disclose
Susanna Varkey Ulahannan
No relevant relationships to disclose
Suzanne Fioravanti
No relevant relationships to disclose
Melissa Walker
No relevant relationships to disclose
William Douglas Figg
No relevant relationships to disclose
Kathryn Compton
No relevant relationships to disclose
Aradhana Venkatesan
No relevant relationships to disclose
Nadine Abi-Jaoudeh
No relevant relationships to disclose
Bradford J. Wood
No relevant relationships to disclose
Tim F. Greten
No relevant relationships to disclose